Fibromyalgia Care Breakthrough: DEA Green Lights Biotech Partnership Exploring Ketamine Implant Therapy
Silo Pharma’s (NASDAQ: SILO) novel ketamine-loaded implant targeting fibromyalgia and chronic pain conditions, SP-26, is reportedly ad
Psyched: Biden Approves Psychedelics Trials, RFK, Australia’s First Legal Dedicated Clinic & More
President Biden Approves Psychedelics Clinical Trials For Active Military Members
President Biden signed into law the 2024 National Defense Authorization Act (NDAA), large-scale legislation that also contains a mandate to fund clinical trials with psychedelics for active service members.
Incannex Healthcare To Open First Psychedelic-Assisted Therapy Clinic In Australia
Melbourne will soon open Clarion Clinics’ first exclusively dedicated facility to provide psychedelic-assisted therapies legalized in Australia.
Inebriation Remedy And Breakthrough MS Treatment: Meet FSD Pharma
Among a biotech space bursting with innovation, one company stands out as it is developing two assets at once: a ready-for-market drink that can take someone from a drinking state to mental and physical composure in record time and a potential breakthrough therapy for Multiple Sclerosis. Meet FSD Pharma (NASDAQ:
Do Psychedelic Treatments Always Require Psychotherapy? Some Say Yes, Others Think It’s ‘Reductionism’
The question of whether psychedelic treatments always require psychotherapy is one hotly debated among researchers, and answers -as well as backstories- vary throughout the whole spectrum.
Psyched: Biden’s Big Decision On Psychedelics Therapy; LSD Anxiety Results; Matthew Perry Autopsy And More
Biden To Decide On Psychedelic Therapy Bill
Cannabis Chart Of The Week: Where Are Sector Leaders Trading Relative To Their 52-Week Highs And Lows?
This week’s Viridian Chart of the Week looks at the stock prices of the leaders in several cannabis sectors, including Agriculture Technology, Cultivation and Retail, Psychedelics, and Financial Services, relative to their 52-week highs and lows. The chart is arranged in increasing order of trading prices relative to 52-week lows within each sector.
Groundbreaking Study: LSD Tartrate Reduces Anxiety Effectively, Says MindMed
Clinical-stage psychedelics biotech Mind Medicine (MindMed) (NASDAQ: MNMD) has published new positive topline results from its Phase 2b study on a single dose of MM-120 (LSD tartrate,) with no additional therapeutic intervention, in Generalized Anxi
More Protocols And Guidance Are Needed As Momentum Builds For Veterans, Psychedelics, And Mental Health
Studies and reports from the U.S. Department of Veterans Affairs (VA) and other research publications suggest that an estimated 20-30% of U.S.
Psyched: John Lennon Remembered, Clinical Trials For Service Members, Chrissy Teigen, Jon Feliciano And More
John Lennon Remembered 43 Years After His Murder In New York, Psychedelic Adventures & Enduring Legacy